Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Hepatocellular × regorafenib × Clear all

Phase

Phase 2 15 Phase NA 2 Phase 1/2 2 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 13 Neoplasm Metastasis 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Carcinoma 2 Adenocarcinoma 2 Spinocerebellar Degenerations 1 HER2-positive Colorectal Cancer 1 Gastrointestinal Stromal Tumors 1 Colorectal Cancer Liver Metastases 1 Carcinoma, Hepatocellular 1 Advanced Colorectal Cancer 1

Interventions

Sorafenib 39 lenvatinib 19 Fluorouracil 14 Oxaliplatin 13 atezolizumab 12 Doxorubicin 12 Bevacizumab 11 Ethiodized Oil 10 Radiosurgery 9 Radiofrequency Ablation 9 Leucovorin 9 Folfox protocol 7 pembrolizumab 6 Epirubicin 6 Cisplatin 6 sintilimab 5 durvalumab 5 Radiotherapy 5 Gemcitabine 5 tremelimumab 4 apatinib 4 Nivolumab 4 Embolization, Therapeutic 4 camrelizumab 3 Tenofovir 3 Pharmaceutical Preparations 3 Mitomycin 3 Hepatectomy 3 Dexamethasone 3 Chemotherapy, Adjuvant 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04777851 2026-03-09

REPLACE

Translational Research in Oncology

Phase 3 Terminated

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡